Early research (Phase 1)UnknownNCT06478381What this trial is testingL218CAR19 in Patients With Relapsed/Refractory B-cell LymphomaWho this might be right forRelapsed/Refractory B-cell Lymphomas Henan Cancer Hospital 22
Testing effectiveness (Phase 2)Study completedNCT01532700What this trial is testingAn Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia (CLL) University Health Network, Toronto 28
Testing effectiveness (Phase 2)Study completedNCT00337168What this trial is testingS0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 36
Very early researchStudy completedNCT01719250What this trial is testingBuparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma+2 more Mayo Clinic 7
Testing effectiveness (Phase 2)Looking for participantsNCT06481735What this trial is testingTCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALLWho this might be right forAcute Lymphocytic Leukemia Chinese PLA General Hospital 30
Early research (Phase 1)UnknownNCT03574168What this trial is testingCD19-CAR-T Cells in Patients With R/R B-ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Bioceltech Therapeutics, Ltd. 40
Early research (Phase 1)Active Not RecruitingNCT04732845What this trial is testingHuman AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid MalignanciesWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia Benjamin Tomlinson 18
Early research (Phase 1)Looking for participantsNCT06313957What this trial is testingLUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin LymphomaWho this might be right forRelapsed B-cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma Peking University Cancer Hospital & Institute 42
Testing effectiveness (Phase 2)Looking for participantsNCT06919939What this trial is testingEpcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell LymphomaWho this might be right forLarge B-cell LymphomaRelapse University of Miami 26
Testing effectiveness (Phase 2)Study completedNCT03310619What this trial is testingA Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell MalignanciesWho this might be right forLymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Follicular Celgene 62
Not applicableStudy completedNCT00060021What this trial is testingAcupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell TransplantationWho this might be right forCancer National Cancer Institute (NCI)
Not applicableStudy completedNCT00964821What this trial is testingFlu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 459
Testing effectiveness (Phase 2)Ended earlyNCT00290706What this trial is testingA Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University 32
Testing effectiveness (Phase 2)Looking for participantsNCT07365306What this trial is testingEpcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Primary Mediastinal Large B-Cell Lymphoma+5 more City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00974233What this trial is testingStudy of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma University of Wisconsin, Madison 34
Testing effectiveness (Phase 2)Study completedNCT00007852What this trial is testingRituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Nebraska 44
Testing effectiveness (Phase 2)Study completedNCT03105336What this trial is testingAxicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin LymphomaWho this might be right forFollicular LymphomaMarginal Zone LymphomaIndolent Non-Hodgkin Lymphoma Kite, A Gilead Company 159
Not applicableNot Yet RecruitingNCT06721598What this trial is testingAn Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative DisordersWho this might be right forNon-Hodgkin Lymphoma, B-cellAcute Lymphoblastic Leukemia ALL National Research Center for Hematology, Russia 60
Testing effectiveness (Phase 2)Study completedNCT00806767What this trial is testingFludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Institut Paoli-Calmettes 82
Testing effectiveness (Phase 2)Study completedNCT01030536What this trial is testingSafety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)Who this might be right forNon-Hodgkin LymphomaChronic Lymphocytic Leukemia MedImmune LLC 23